BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2832180)

  • 21. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2.
    Rollins SA; Kennedy SP; Chodera AJ; Elliott EA; Zavoico GB; Matis LA
    Transplantation; 1994 Jun; 57(12):1709-16. PubMed ID: 7912457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin 2 and low molecular weight B cell growth factor are T cell-replacing factors for different subpopulations of human B cells.
    Callard RE; Smith SH
    Eur J Immunol; 1988 Oct; 18(10):1635-8. PubMed ID: 3263924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human T cell-replacing factor(s): a comparison of recombinant and purified human B cell growth and differentiation factors.
    Smith SH; Shields JG; Callard RE
    Eur J Immunol; 1989 Nov; 19(11):2045-9. PubMed ID: 2689186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT; Springgate CF; Piela TH; Choi YS
    J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of monoclonal antibodies to the alpha and beta chains of the human lymphocyte function-associated (H-LFA-1) antigen on T lymphocyte functions.
    Dongworth DW; Gotch FM; Hildreth JE; Morris A; McMichael AJ
    Eur J Immunol; 1985 Sep; 15(9):888-92. PubMed ID: 3930261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
    Griffin H; Rowe M; Murray R; Brooks J; Rickinson A
    Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation by Ly-5 and Lyb-2 of IgG production induced by lipopolysaccharide and B cell stimulatory factor-1 (IL-4).
    Yakura H; Kawabata I; Ashida T; Katagiri M
    J Immunol; 1988 Aug; 141(3):875-80. PubMed ID: 3260915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection of Epstein-Barr virus-transformed lymphoblastoid B cells by the human immunodeficiency virus: evidence for a persistent and productive infection leading to B cell phenotypic changes.
    De Rossi A; Roncella S; Calabro ML; D'Andrea E; Pasti M; Panozzo M; Mammano F; Ferrarini M; Chieco-Bianchi L
    Eur J Immunol; 1990 Sep; 20(9):2041-9. PubMed ID: 2170147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 4 (BSF-1) induces growth in resting murine CD8 T cells triggered via cross-linking of T3 cell surface structures.
    Miethke T; Schmidberger R; Heeg K; Gillis S; Wagner H
    Eur J Immunol; 1988 May; 18(5):767-72. PubMed ID: 2967763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triggering of co-mitogenic signals in T cell proliferation by anti-LFA-1 (CD18, CD11a), LFA-3, and CD7 monoclonal antibodies.
    Carrera AC; Rincón M; Sánchez-Madrid F; López-Botet M; de Landaźuri MO
    J Immunol; 1988 Sep; 141(6):1919-24. PubMed ID: 2459196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
    Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
    Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low molecular weight B cell growth factor-responsive cloned human B cell lines. I. Phenotypic differences and lack of requirement for CD23 (Fc epsilon RII).
    Warrington RJ; Rutherford WJ; Wong SK; Cook JM; Rector ES
    J Immunol; 1989 Oct; 143(8):2546-52. PubMed ID: 2529311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
    Damle NK; Doyle LV
    J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3.
    Selvaraj P; Plunkett ML; Dustin M; Sanders ME; Shaw S; Springer TA
    Nature; 1987 Mar 26-Apr 1; 326(6111):400-3. PubMed ID: 2951597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human B lymphoblastoid cell lines provide an interleukin 1-like signal for mitogen-treated T lymphocytes via direct cell contact.
    Arnold A; Lipkowitz S; Suthanthiran M; Novogrodsky A; Stenzel KH
    J Immunol; 1985 Jun; 134(6):3876-81. PubMed ID: 2985701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Function of the LFA-1 and T4 molecules in the direct activation of resting human B lymphocytes by T lymphocytes.
    Tedder TF; Schmidt RE; Rudd CE; Kornacki MM; Ritz J; Schlossman SF
    Eur J Immunol; 1986 Dec; 16(12):1539-43. PubMed ID: 3102246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a monoclonal antibody, anti-6C2, which is involved in the interaction of CD4 T helper cells and activated B cells.
    Torimoto Y; Sugita K; Weinberg DS; Dang NH; Donahue C; Letvin NL; Schlossman SF; Morimoto C
    J Immunol; 1991 Apr; 146(7):2176-84. PubMed ID: 1706389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
    Tosato G; Gerrard TL; Goldman NG; Pike SE
    J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.